RE: Asked B4Pretty much would have to be a fly on the wall in the lab and in the boardroom to know the exact upside, which probably constantly changes with each new development in science. In my perfect world, I wouldn't turn down $50 US/share, with an equal number of RVX Therapeutics spin-off shares thrown my way for good measure. Pie in the sky? Probably. But if you're going to dream, might as well dream big. IMHO